Man Group plc - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
Man Group plc ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$6,116,612
-22.0%
68,281
-25.9%
0.02%
-20.8%
Q2 2023$7,846,247
+46.4%
92,157
+42.3%
0.02%
+26.3%
Q1 2023$5,360,463
-4.5%
64,779
-9.2%
0.02%
-5.0%
Q4 2022$5,612,149
+3.1%
71,356
-3.0%
0.02%
-20.0%
Q3 2022$5,445,000
-21.5%
73,559
-30.9%
0.02%
-13.8%
Q2 2022$6,937,000
+0.6%
106,428
-2.4%
0.03%
+20.8%
Q1 2022$6,893,000
+18.8%
109,035
-0.3%
0.02%
+26.3%
Q4 2021$5,802,000
-24.0%
109,390
+1.1%
0.02%
-29.6%
Q3 2021$7,638,000
+8.2%
108,197
+2.2%
0.03%
+8.0%
Q2 2021$7,058,000
+155.6%
105,914
+325.8%
0.02%
+108.3%
Q1 2021$2,761,000
+3.6%
24,872
+10.9%
0.01%0.0%
Q4 2020$2,664,000
-59.1%
22,430
-70.0%
0.01%
-53.8%
Q3 2020$6,520,000
-44.6%
74,725
-43.1%
0.03%
-55.9%
Q2 2020$11,765,000
+43.6%
131,371
+59.8%
0.06%
+11.3%
Q1 2020$8,193,000
-13.8%
82,211
-0.6%
0.05%
+71.0%
Q4 2019$9,501,000
-57.5%
82,686
-53.3%
0.03%
-62.7%
Q3 2019$22,332,000
+8.4%
177,039
+3.4%
0.08%
+12.2%
Q2 2019$20,601,000
+30.1%
171,193
-5.4%
0.07%
+23.3%
Q1 2019$15,836,000
-28.8%
181,013
-18.6%
0.06%
-39.4%
Q4 2018$22,257,000
-72.4%
222,456
-68.4%
0.10%
-66.3%
Q3 2018$80,564,000
+46.7%
703,120
+14.8%
0.29%
+30.1%
Q2 2018$54,910,000
+473.5%
612,297
+367.9%
0.23%
+413.6%
Q1 2018$9,574,000130,8580.04%
Other shareholders
HAEMONETICS CORP shareholders Q1 2021
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders